SEC Info℠ | Home | Search | My Interests | Help | Sign In | Please Sign In | ||||||||||||||||||||
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 12/11/18 Emmaus Life Sciences, Inc. 10-K 9/30/18 77:6.9M S2 Filings LLC/FA |
Document/Exhibit Description Pages Size 1: 10-K Annual Report HTML 930K 2: EX-10.13 Material Contract HTML 54K 3: EX-10.14 Material Contract HTML 53K 4: EX-10.15 Material Contract HTML 37K 5: EX-23.1 Consent of Experts or Counsel HTML 21K 6: EX-31.1 Certification -- §302 - SOA'02 HTML 26K 7: EX-31.2 Certification -- §302 - SOA'02 HTML 26K 8: EX-32.1 Certification -- §906 - SOA'02 HTML 22K 9: EX-32.2 Certification -- §906 - SOA'02 HTML 22K 16: R1 Document and Entity Information HTML 58K 17: R2 Consolidated Balance Sheets HTML 126K 18: R3 Consolidated Balance Sheets (Parenthetical) HTML 49K 19: R4 Consolidated Statements of Operations HTML 78K 20: R5 Consolidated Statements of Changes in Equity HTML 104K 21: R6 Consolidated Statements of Cash Flows HTML 119K 22: R7 Consolidated Statements of Cash Flows HTML 24K (Parenthetical) 23: R8 Nature of Operations HTML 32K 24: R9 Summary of Significant Accounting Policies HTML 90K 25: R10 Accounts Receivable, Net HTML 27K 26: R11 Long - Term Borrowings and Other Note Payables HTML 26K 27: R12 Acquisition HTML 47K 28: R13 Stockholders' Equity HTML 207K 29: R14 Convertible Preferred Stock HTML 39K 30: R15 Income Taxes HTML 67K 31: R16 Related Party Transactions HTML 29K 32: R17 Loss Per Share HTML 37K 33: R18 Commitments and Contingent Liabilities HTML 33K 34: R19 Significant Customers HTML 23K 35: R20 Subsequent Events HTML 32K 36: R21 Summary of Significant Accounting Policies HTML 165K (Policies) 37: R22 Summary of Significant Accounting Policies HTML 26K (Tables) 38: R23 Accounts Receivable, Net (Tables) HTML 28K 39: R24 Acquisition (Tables) HTML 46K 40: R25 Stockholders' Equity (Tables) HTML 176K 41: R26 Income Taxes (Tables) HTML 67K 42: R27 Loss Per Share (Tables) HTML 37K 43: R28 Commitments and Contingent Liabilities (Tables) HTML 28K 44: R29 Nature of Operations (Details Narrative) HTML 32K 45: R30 Summary of Significant Accounting Policies HTML 32K (Details ) 46: R31 Summary of Significant Accounting Policies HTML 31K (Details Narrative) 47: R32 Summary of Significant Accounting Policies HTML 71K (Details Narrative 1) 48: R33 Accounts Receivable, Net (Details) HTML 29K 49: R34 Long - Term Borrowings and Other Note Payables HTML 48K (Details Narrative) 50: R35 Acquisition (Details) HTML 67K 51: R36 Acquisition (Details 1) HTML 29K 52: R37 Acquisition (Details Narrative) HTML 57K 53: R38 Stockholders' Equity (Details) HTML 34K 54: R39 Stockholders' Equity (Details 1) HTML 27K 55: R40 Stockholders' Equity (Details 2) HTML 56K 56: R41 Stockholders' Equity (Details 3) HTML 123K 57: R42 Stockholders' Equity (Details 4) HTML 50K 58: R43 Stockholders' Equity (Details 5) HTML 34K 59: R44 Stockholders' Equity (Details 6) HTML 43K 60: R45 Stockholders' Equity (Details 7) HTML 63K 61: R46 Stockholders' Equity (Details Narrative) HTML 215K 62: R47 Stockholders' Equity (Details Narrative 1) HTML 101K 63: R48 Convertible Preferred Stock (Details Narrative) HTML 59K 64: R49 Income Taxes (Details) HTML 45K 65: R50 Income Taxes (Details 1) HTML 40K 66: R51 Income Taxes (Details 2) HTML 44K 67: R52 Income Taxes (Details 3) HTML 42K 68: R53 Income Taxes (Details Narrative) HTML 36K 69: R54 Related Party Transactions (Details Narrative) HTML 61K 70: R55 Loss Per Share (Details) HTML 48K 71: R56 Commitments and Contingent Liabilities (Details) HTML 25K 72: R57 Commitments and Contingent Liabilities (Details HTML 42K Narrative) 73: R58 Significant Customers (Details Narrative) HTML 31K 74: R59 Subsequent Events (Details Narrative) HTML 60K 76: XML IDEA XML File -- Filing Summary XML 131K 75: EXCEL IDEA Workbook of Financial Reports XLSX 100K 10: EX-101.INS XBRL Instance -- mynd-20180930 XML 1.87M 12: EX-101.CAL XBRL Calculations -- mynd-20180930_cal XML 199K 13: EX-101.DEF XBRL Definitions -- mynd-20180930_def XML 782K 14: EX-101.LAB XBRL Labels -- mynd-20180930_lab XML 1.28M 15: EX-101.PRE XBRL Presentations -- mynd-20180930_pre XML 1.00M 11: EX-101.SCH XBRL Schema -- mynd-20180930 XSD 198K 77: ZIP XBRL Zipped Folder -- 0001615774-18-014245-xbrl Zip 174K
Exhibit 23.1
Independent Registered Public Accounting Firm’s Consent
We consent to the incorporation by reference in the Registration Statement of MYnd Analytics, Inc. on Form S-8 (File Nos. 333-215434, 333-166394 and 333-225050), Form S-1 (File Nos. 333-217092, 333-215323, 333-215397 and 333-225052) and Form S-3 (File Nos. 333-223203 and 333-225100) of our report which includes an explanatory paragraph as to the Company’s ability to continue as a going concern, dated December 11, 2018 with respect to our audits of the consolidated financial statements of MYnd Analytics, Inc. as of September 30, 2018 and 2017 and for the years then ended, which report is included in this Annual Report on Form 10-K of MYnd Analytics, Inc. for the year ended September 30, 2018.
/s/ Marcum llp
Marcum llp
Costa Mesa, CA
C:
This ‘10-K’ Filing | Date | Other Filings | ||
---|---|---|---|---|
Filed on: | 12/11/18 | |||
For Period end: | 9/30/18 | |||
9/30/17 | 10-K | |||
List all Filings |
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 3/31/23 Emmaus Life Sciences, Inc. 10-K 12/31/22 88:18M Donnelley … Solutions/FA 3/31/22 Emmaus Life Sciences, Inc. 10-K 12/31/21 98:18M ActiveDisclosure/FA 8/10/21 Emmaus Life Sciences, Inc. 10-K/A 12/31/20 92:18M ActiveDisclosure/FA 5/04/21 Emmaus Life Sciences, Inc. 10-K 12/31/20 97:18M ActiveDisclosure/FA 1/25/21 Emmaus Life Sciences, Inc. 10-K 12/31/19 121:29M ActiveDisclosure/FA 5/30/19 SEC UPLOAD¶ 6/27/19 2:45K Emmaus Life Sciences, Inc. 5/02/19 SEC UPLOAD¶ 6/27/19 2:53K Emmaus Life Sciences, Inc. |